# Study of SAB-176 in Healthy Adult Participants

> **NCT04850898** · PHASE2 · COMPLETED · sponsor: **SAb Biotherapeutics, Inc.** · enrollment: 62 (actual)

## Conditions studied

- Influenza A H1N1

## Interventions

- **BIOLOGICAL:** SAB-176
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04850898
- **Lead sponsor:** SAb Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-23
- **Primary completion:** 2021-10-08
- **Final completion:** 2021-10-08
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2025-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04850898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04850898, "Study of SAB-176 in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04850898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*